European society of cardiology (ESC) annual congress report from Barcelona 2017

Kimio Satoh; Jun Takahashi; Yasuharu Matsumoto; Shunsuke Tatebe; Tatsuo Aoki; Yoku Kikuchi; Kiyotaka Hao; Kazuma Ohyama; Masamichi Nogi; Akira Suda; Shintaro Kasahara; Koichi Sato; Sadamitsu Ichijo; Hiroaki Shimokawa

doi:10.1253/circj.CJ-17-1103

European society of cardiology (ESC) annual congress report from Barcelona 2017

Kimio Satoh, Jun Takahashi, Yasuharu Matsumoto, Shunsuke Tatebe, Tatsuo Aoki, Yoku Kikuchi, Kiyotaka Hao, Kazuma Ohyama, Masamichi Nogi, Akira Suda, Shintaro Kasahara, Koichi Sato, Sadamitsu Ichijo, Hiroaki Shimokawa

Research output: Contribution to journal › Article › peer-review

2 Citations (Scopus)

Abstract

From August 26th to 30th, the 2017 Annual Congress of the European Society of Cardiology (ESC 2017) was held in Barcelona, Spain. Despite the terrorism tradegy just before the ESC congress, the congress attracted many medical professionals from all over the world to discuss the recent topics in cardiovascular medicine in more than 500 sessions, including COMPASS (Cardiovascular OutcoMes for People using Anticoagulation StrategieS Trial), CANTOS (Canakinumab Anti-Inflammatory Thrombosis Outcomes Study), and ORION (which assessed the effect of a novel siRNA inhibitor to PCSK9 on reductions in low-density lipoprotein cholesterol). Japanese cardiologists and the Japanese Circulation Society greatly contributed to the congress. This report briefly introduces some late-breaking registry results, late-breaking clinical trials, and ESC Guidelines from the ESC 2017 Congress.

Original language	English
Pages (from-to)	1758-1763
Number of pages	6
Journal	Circulation Journal
Volume	81
Issue number	12
DOIs	https://doi.org/10.1253/circj.CJ-17-1103
Publication status	Published - 2017

Keywords

Cardiology
European Society of Cardiology

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1253/circj.CJ-17-1103

Cite this

@article{0b075fed603a40e1878be138494c16a1,

title = "European society of cardiology (ESC) annual congress report from Barcelona 2017",

abstract = "From August 26th to 30th, the 2017 Annual Congress of the European Society of Cardiology (ESC 2017) was held in Barcelona, Spain. Despite the terrorism tradegy just before the ESC congress, the congress attracted many medical professionals from all over the world to discuss the recent topics in cardiovascular medicine in more than 500 sessions, including COMPASS (Cardiovascular OutcoMes for People using Anticoagulation StrategieS Trial), CANTOS (Canakinumab Anti-Inflammatory Thrombosis Outcomes Study), and ORION (which assessed the effect of a novel siRNA inhibitor to PCSK9 on reductions in low-density lipoprotein cholesterol). Japanese cardiologists and the Japanese Circulation Society greatly contributed to the congress. This report briefly introduces some late-breaking registry results, late-breaking clinical trials, and ESC Guidelines from the ESC 2017 Congress.",

keywords = "Cardiology, European Society of Cardiology",

author = "Kimio Satoh and Jun Takahashi and Yasuharu Matsumoto and Shunsuke Tatebe and Tatsuo Aoki and Yoku Kikuchi and Kiyotaka Hao and Kazuma Ohyama and Masamichi Nogi and Akira Suda and Shintaro Kasahara and Koichi Sato and Sadamitsu Ichijo and Hiroaki Shimokawa",

note = "Funding Information: The authors thank Takashi Amano and Shizuka Yamada, the JCS Office, for collaborating with this report. Publisher Copyright: {\textcopyright} 2017, Japanese Circulation Society. All rights reserved.",

year = "2017",

doi = "10.1253/circj.CJ-17-1103",

language = "English",

volume = "81",

pages = "1758--1763",

journal = "Circulation Journal",

issn = "1346-9843",

publisher = "Japanese Circulation Society",

number = "12",

}

TY - JOUR

T1 - European society of cardiology (ESC) annual congress report from Barcelona 2017

AU - Satoh, Kimio

AU - Takahashi, Jun

AU - Matsumoto, Yasuharu

AU - Tatebe, Shunsuke

AU - Aoki, Tatsuo

AU - Kikuchi, Yoku

AU - Hao, Kiyotaka

AU - Ohyama, Kazuma

AU - Nogi, Masamichi

AU - Suda, Akira

AU - Kasahara, Shintaro

AU - Sato, Koichi

AU - Ichijo, Sadamitsu

AU - Shimokawa, Hiroaki

N1 - Funding Information: The authors thank Takashi Amano and Shizuka Yamada, the JCS Office, for collaborating with this report. Publisher Copyright: © 2017, Japanese Circulation Society. All rights reserved.

PY - 2017

Y1 - 2017

N2 - From August 26th to 30th, the 2017 Annual Congress of the European Society of Cardiology (ESC 2017) was held in Barcelona, Spain. Despite the terrorism tradegy just before the ESC congress, the congress attracted many medical professionals from all over the world to discuss the recent topics in cardiovascular medicine in more than 500 sessions, including COMPASS (Cardiovascular OutcoMes for People using Anticoagulation StrategieS Trial), CANTOS (Canakinumab Anti-Inflammatory Thrombosis Outcomes Study), and ORION (which assessed the effect of a novel siRNA inhibitor to PCSK9 on reductions in low-density lipoprotein cholesterol). Japanese cardiologists and the Japanese Circulation Society greatly contributed to the congress. This report briefly introduces some late-breaking registry results, late-breaking clinical trials, and ESC Guidelines from the ESC 2017 Congress.

AB - From August 26th to 30th, the 2017 Annual Congress of the European Society of Cardiology (ESC 2017) was held in Barcelona, Spain. Despite the terrorism tradegy just before the ESC congress, the congress attracted many medical professionals from all over the world to discuss the recent topics in cardiovascular medicine in more than 500 sessions, including COMPASS (Cardiovascular OutcoMes for People using Anticoagulation StrategieS Trial), CANTOS (Canakinumab Anti-Inflammatory Thrombosis Outcomes Study), and ORION (which assessed the effect of a novel siRNA inhibitor to PCSK9 on reductions in low-density lipoprotein cholesterol). Japanese cardiologists and the Japanese Circulation Society greatly contributed to the congress. This report briefly introduces some late-breaking registry results, late-breaking clinical trials, and ESC Guidelines from the ESC 2017 Congress.

KW - Cardiology

KW - European Society of Cardiology

UR - http://www.scopus.com/inward/record.url?scp=85035194313&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85035194313&partnerID=8YFLogxK

U2 - 10.1253/circj.CJ-17-1103

DO - 10.1253/circj.CJ-17-1103

M3 - Article

C2 - 29093432

AN - SCOPUS:85035194313

SN - 1346-9843

VL - 81

SP - 1758

EP - 1763

JO - Circulation Journal

JF - Circulation Journal

IS - 12

ER -

European society of cardiology (ESC) annual congress report from Barcelona 2017

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this